22.72
price down icon0.39%   -0.09
 
loading
전일 마감가:
$22.81
열려 있는:
$22.81
하루 거래량:
75,610
Relative Volume:
0.36
시가총액:
$324.03M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+1.70%
1개월 성능:
+34.60%
6개월 성능:
+50.86%
1년 성능:
-46.79%
1일 변동 폭
Value
$22.01
$23.17
1주일 범위
Value
$20.80
$23.53
52주 변동 폭
Value
$6.875
$74.49

Neurogene Inc Stock (NGNE) Company Profile

Name
명칭
Neurogene Inc
Name
전화
(877) 237-5020
Name
주소
535 W 24TH STREET, NEW YORK
Name
직원
107
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
NGNE's Discussions on Twitter

NGNE을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
NGNE
Neurogene Inc
22.72 325.32M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Neurogene Inc Stock (NGNE) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-17 개시 Craig Hallum Buy
2025-05-16 다운그레이드 Robert W. Baird Outperform → Neutral
2024-06-27 개시 BMO Capital Markets Outperform
2024-06-11 개시 Robert W. Baird Outperform
2024-04-29 개시 Leerink Partners Outperform
2024-03-21 개시 William Blair Outperform
2024-01-08 개시 H.C. Wainwright Buy
2024-01-05 개시 Stifel Buy
2024-01-04 개시 TD Cowen Outperform
모두보기

Neurogene Inc 주식(NGNE)의 최신 뉴스

pulisher
Jul 25, 2025

Is Neurogene Inc. a good long term investmentStrong return on investment - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

What drives Neurogene Inc. stock priceAccelerated capital growth - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Neurogene Inc. Stock Analysis and ForecastExplosive capital gains - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Rett bet set includes Neurogene, Taysha gene therapies - BioWorld MedTech

Jul 24, 2025
pulisher
Jul 22, 2025

What analysts say about Neurogene Inc. stockFree Market Dynamics Reports - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Neurogene Inc. stock price move sharplyReal Time Stock Signal - Newser

Jul 22, 2025
pulisher
Jul 18, 2025

how neurogene inc. stock performs during market volatilityDefensive Stock Picks with Upside - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

How Neurogene Inc. stock performs during market volatilityHigh Return Conservative Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Neurogene Inc. stock attracts strong analyst attentionFree Investment Community - Newser

Jul 15, 2025
pulisher
Jul 05, 2025

Neurogene announces inducement grants - Medical Buyer

Jul 05, 2025
pulisher
Jul 03, 2025

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jul 03, 2025
pulisher
Jul 03, 2025

Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Jul 03, 2025
pulisher
Jul 01, 2025

Neurogene jumps as FDA approves rare gene therapy trial design - TradingView

Jul 01, 2025
pulisher
Jul 01, 2025

Stifel reiterates Buy rating on Neurogene stock, backs pivotal trial design - Investing.com UK

Jul 01, 2025
pulisher
Jun 30, 2025

FDA approves Neurogene’s Rett syndrome gene therapy registrational trial design - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Neurogene Announces Registrational Trial Design for Embolden™ Study of NGN-401 Gene Therapy for Rett Syndrome - Business Wire

Jun 30, 2025
pulisher
Jun 30, 2025

Neurogene Inc.(NasdaqGM: NGNE) dropped from Russell 3000E Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 18, 2025

Craig-Hallum bullish on Neurogene, initiates with a Buy - Yahoo Finance

Jun 18, 2025
pulisher
Jun 18, 2025

Neurogene (NASDAQ:NGNE) Coverage Initiated by Analysts at Craig Hallum - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

Neurogene (NGNE) Receives New Buy Rating from Craig-Hallum | NGN - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Neurogene (NGNE) Gains Attention with Promising Gene Therapy for - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Neurogene (NGNE) Receives Positive Coverage with a $50 Price Tar - GuruFocus

Jun 17, 2025

Neurogene Inc (NGNE) 재무 분석

Neurogene Inc (NGNE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):